semaglutide cardiac protection FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Semaglutide lowers cardiovascular events even

This is an intentional additive that addresses a real nutritional concern that semaglutide creates in the body

Both Wegovy and Zepbound have warnings in their US prescribing information about the risk of suicidal behavior and ideation, noting that those risks have been reported in clinical trials with other chronic weight management products and recommending that patients be monitored for that risk

Referral to a registered dietitian with experience in neuromuscular conditions is valuable, as they can develop an individualised eating plan that addresses both weight management goals and the specific challenges faced by MG patients, such as dysphagia or fatigue affecting meal preparation

CardioNerds Cardioobstetrics Production Team full 45:28 122

Importantly, treatment with retatrutide not only resulted in robust weight reduction, but also in clear improvements in assessed cardiometabolic health measures. The Triumph clinical trial program has been running since 2023, and more than 5,800 participants have been enrolled on the study

Solution: be patient through the titration period